Investor InformationCorporate GovernanceNews Releases

Corporate Overview

Corporate Profile

ArthroCare develops and manufactures surgical devices, instruments, and implants that strive to enhance surgical techniques as well as improve patient outcomes. Its devices improve many existing surgical procedures and enable new minimally invasive procedures. Many of ArthroCare's devices use its internationally patented Coblation® technology. This technology precisely dissolves target tissue and limits damage to surrounding healthy tissue. ArthroCare also develops surgical devices utilizing other patented technology including its OPUS® line of fixation products as well as re-usable surgical instruments. ArthroCare is leveraging these technologies in order to offer a comprehensive line of surgical devices to capitalize on a multi-billion dollar market opportunity across several surgical specialties, including its two core product areas consisting of Sports Medicine and Ear, Nose, and Throat as well as other areas such as spine, wound care, urology and gynecology.

For Financial Tearsheet click here

For Corporate Highlights click here

For Code Of Business Conduct And Ethics click here



Shareholder Information

ARTC (Common)
ExchangeNASDAQ GS (US Dollar)
Price$48.60
Change (%) + 0.04 (0.08%)
Volume916,400
Data as of 05/29/14 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote

Recent News

ArthroCare Reports First Quarter 2014 Financial Results - 05/02/14
AUSTIN, Texas--(BUSINESS WIRE)--May 2, 2014-- ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced its financial results for the quarter ended March 31, 2014. ... More >>
ArthroCare Reports Fourth Quarter and Full Year 2013 Financial Results - 02/13/14
AUSTIN, Texas--(BUSINESS WIRE)--Feb. 13, 2014-- ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced its financial results for the quarter ended and year ended ... More >>
ArthroCare Announces Entry into a Deferred Prosecution Agreement - 01/07/14
AUSTIN, Texas--(BUSINESS WIRE)--Jan. 7, 2014-- ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, and the U.S. Department of Justice (“DOJ”) entered into a Deferred Pro... More >>
ArthroCare Announces Participation in Investor Conference - 01/06/14
AUSTIN, Texas--(BUSINESS WIRE)--Jan. 6, 2014-- ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced today participation in an upcoming investor conference, as d... More >>
ArthroCare Announces Participation in Investor Conference - 11/25/13
AUSTIN, Texas--(BUSINESS WIRE)--Nov. 25, 2013-- ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced today participation in an upcoming investor conference, as ... More >>
ArthroCare Reports Third Quarter 2013 Financial Results - 10/29/13
AUSTIN, Texas--(BUSINESS WIRE)--Oct. 29, 2013-- ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced its financial results for the quarter ended September 30, 2... More >>
ArthroCare Announces Date for Third Quarter 2013 Financial Results Press Release and Conference Call - 10/25/13
AUSTIN, Texas--(BUSINESS WIRE)--Oct. 25, 2013-- ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, plans to announce its third quarter 2013 results on Tuesday, October ... More >>
ArthroCare Reports Second Quarter 2013 Financial Results - 08/05/13
AUSTIN, Texas--(BUSINESS WIRE)--Aug. 5, 2013-- ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced its financial results for the quarter ended June 30, 2013. ... More >>
ArthroCare Announces Date for Second Quarter 2013 Financial Results Press Release and Conference Call - 08/02/13
AUSTIN, Texas--(BUSINESS WIRE)--Aug. 2, 2013-- ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, plans to announce its second quarter 2013 results on Monday, August 5,... More >>
ArthroCare Announces Acquisition of ENTrigue Surgical, Inc. - 07/02/13
AUSTIN, Texas--(BUSINESS WIRE)--Jul. 2, 2013-- ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, today announced that it has completed the acquisition of ENTrigue Surg... More >>
Transfer Agent
American Stock Transfer & Trust Company, LLC
6201 15th Avenue
Brooklyn, NY 11219
Phone: 718-921-8200
Fax: 718.921.8355
E-mail: info@amstock.com

Investor Relations Contact
Investor Relations
Phone: (512) 391-3900
E-mail: Investor-relations@arthrocare.com

Corporate Headquarters
ArthroCare Corporation
7000 West William Cannon Bldg 1
Austin, TX 78735
U.S.A.
Quotes delayed at least 15 minutes. Market data provided by Interactive Data.

Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions.

 
  back to topback to top